(Q33504926)

27 July 2017

title

Acute renal insufficiency and cerebral infarction during high-dose intravenous immunoglobulin therapy (English)

1 reference

27 July 2017

1 reference

C Chatot-Henry

1

1 reference

27 July 2017

D Smadja

2

1 reference

27 July 2017

H Mehdaoui

3

1 reference

27 July 2017

P Fournerie

4

1 reference

27 July 2017

J N Drault

5

1 reference

27 July 2017

A Brébion

6

1 reference

27 July 2017

G Sobesky

7

1 reference

27 July 2017

language of work or name

French

0 references

publication date

1 December 1998

1 reference

Revue de Médecine Interne

27 July 2017

published in

1 reference

27 July 2017

volume

19

1 reference

27 July 2017

issue

12

1 reference

27 July 2017

page(s)

914-916

1 reference

Complications of intravenous immune globulin treatment in neurologic disease

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

High-dose intravenous immune globulin and acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

Acute renal failure resulting from intravenous immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

Acute renal failure following immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

Acute renal failure associated with immunoglobulin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

[Acute renal failure due to immunoglobulins]

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

Immunoglobulins and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

Cerebral infarction following intravenous immunoglobulin therapy for myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

Effect of high-dose intravenous immunoglobulin therapy on blood rheology

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

Anterior Choroidal Artery-Territory Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980064-2

7 January 2021

10.1016/S0248-8663(99)80064-2

Identifiers

DOI

1 reference

27 July 2017

1 reference